New hope for pancreatic cancer? trial tests drug combo
Disease control
Terminated
This study tested a new drug called ABTL0812 combined with standard chemotherapy for people with advanced pancreatic cancer that has spread. The goal was to see if the combination is safe and works better than chemo alone. The trial was suspended, so results are not yet available…
Phase: PHASE1, PHASE2 • Sponsor: Ability Pharmaceuticals SL • Aim: Disease control
Last updated May 15, 2026 11:56 UTC